Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 32.70% vs -37.99% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 18.18% vs 0.00% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -1.20% vs -1.32% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 16.36% vs 5.95% in Mar 2024
Compare Balance Sheet Results of Shukra Pharma.
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
43.79
10.38
33.41
321.87%
Share Warrants & Outstandings
Total Reserve
19.05
255.47
-236.42
-92.54%
Shareholder's Funds
62.84
265.84
-203.00
-76.36%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
3.11
15.12
-12.01
-79.43%
Secured Loans
1.64
15.12
-13.48
-89.15%
Unsecured Loans
1.48
0.00
1.48
0.00%
Deferred Tax Assets / Liabilities
3.41
-1.61
5.02
311.80%
Other Long Term Liabilities
0.13
0.00
0.13
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.25
-0.25
-100.00%
Total Non-Current Liabilities
6.65
13.76
-7.11
-51.67%
Current Liabilities
Trade Payables
9.22
55.79
-46.57
-83.47%
Other Current Liabilities
4.27
16.22
-11.95
-73.67%
Short Term Borrowings
1.06
97.33
-96.27
-98.91%
Short Term Provisions
2.74
0.16
2.58
1,612.50%
Total Current Liabilities
17.28
169.51
-152.23
-89.81%
Total Liabilities
86.77
449.11
-362.34
-80.68%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
43.42
229.75
-186.33
-81.10%
Less: Accumulated Depreciation
24.03
85.29
-61.26
-71.83%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
19.40
144.47
-125.07
-86.57%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
1.95
0.00
1.95
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
3.55
-3.55
-100.00%
Long Term Loans & Advances
0.00
11.53
-11.53
-100.00%
Other Non Current Assets
0.00
4.66
-4.66
-100.00%
Total Non-Current Assets
21.34
164.20
-142.86
-87.00%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
9.95
83.47
-73.52
-88.08%
Sundry Debtors
8.77
155.90
-147.13
-94.37%
Cash and Bank
12.12
14.29
-2.17
-15.19%
Other Current Assets
20.17
12.79
7.38
57.70%
Short Term Loans and Advances
14.42
18.46
-4.04
-21.89%
Total Current Assets
65.43
284.90
-219.47
-77.03%
Net Current Assets (Including Current Investments)
48.14
115.40
-67.26
-58.28%
Total Current Assets Excluding Current Investments
65.43
284.90
-219.47
-77.03%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
86.77
449.11
-362.34
-80.68%
Contingent Liabilities
1.40
36.98
-35.58
-96.21%
Total Debt
4.18
112.45
-108.27
-96.28%
Book Value per share (adjusted)
1.44
255.44
-254.00
-99.44%
Annual - Borrowings
Borrowings 4.18 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 32.70% vs -37.99% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.13 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 18.18% vs 0.00% in Mar 2024
Annual - Fixed Assets
Fixed Assets 21.34 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -1.20% vs -1.32% in Mar 2024
Annual - Investments
Investments 0.00 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 65.43 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 16.36% vs 5.95% in Mar 2024
